Effect of obstructive sleep apnea on type 2 diabetes mellitus: A comprehensive literature review.

Obstructive sleep apnea (OSA) is frequently associated with obesity and metabolic syndrome. Also frequently associated with metabolic syndrome is type 2 diabetes mellitus (T2DM). Therefore, it is common to find OSA and T2DM together in individuals with metabolic syndrome. Additionally, both OSA and T2DM have a common pathophysiological link with development of insulin resistance. Individuals with severe insulin resistance are likely to have inadequate glycemic control. Long standing poorly controlled T2DM is associated with debilitating microvascular complications such as retinopathy, nephropathy, neuropathy and macrovascular complications such as coronary artery and cerebrovascular disease. There is extensively published literature exploring the cause-effect relationship between OSA and T2DM. In this article we provide an in-depth review of the complex pathophysiological mechanisms linking OSA to T2DM. Specifically, this review focusses on the effect of OSA on the microvascular complications of T2DM such as retinopathy, nephropathy and neuropathy. Additionally, we review the current literature on the effect of continuous positive airway pressure use in individuals with T2DM and OSA.

[1]  A. Elmarakby,et al.  Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. , 2012, Cardiovascular therapeutics.

[2]  R. Klein,et al.  Sleep-disordered breathing is not associated with the presence of retinal microvascular abnormalities: the Sleep Heart Health Study. , 2004, Sleep.

[3]  T. Çiftçi,et al.  The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. , 2004, Cytokine.

[4]  E. Agardh,et al.  TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. , 2008, Journal of diabetes and its complications.

[5]  P. Cistulli,et al.  Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. , 1994, The Journal of clinical endocrinology and metabolism.

[6]  J. Groves,et al.  Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  J. Ficker,et al.  Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. , 2004, American journal of respiratory and critical care medicine.

[8]  J. Born,et al.  Hypoxia causes glucose intolerance in humans. , 2004, American journal of respiratory and critical care medicine.

[9]  C. Guilleminault,et al.  Selected cardiovascular risk factors in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure (n-CPAP). , 1993, Sleep.

[10]  S. Redline,et al.  Sleep-Disordered Breathing and Impaired Glucose Metabolism in Normal-Weight and Overweight/Obese Individuals , 2008, Diabetes Care.

[11]  S. Surani,et al.  Effect of continuous positive airway pressure therapy on glucose control. , 2012, World journal of diabetes.

[12]  K. Gourgoulianis,et al.  Association of Sleep Apnea Severity and Obesity with Insulin Resistance, C-Reactive Protein, and Leptin Levels in Male Patients with Obstructive Sleep Apnea , 2008, Lung.

[13]  Naresh M Punjabi,et al.  Effects of sleep fragmentation on glucose metabolism in normal subjects. , 2010, Chest.

[14]  S. Shott,et al.  Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. , 2005, Archives of internal medicine.

[15]  I. Idris,et al.  Obstructive sleep apnoea is associated with the development and progression of diabetic retinopathy, independent of conventional risk factors and novel biomarkers for diabetic retinopathy , 2012, British Journal of Ophthalmology.

[16]  D. Kripke,et al.  Sleep-disordered breathing in community-dwelling elderly. , 1991, Sleep.

[17]  A. Banga,et al.  Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. , 2007, Sleep medicine.

[18]  Anne Newman,et al.  Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. , 2003, Diabetes care.

[19]  E. Hahn,et al.  Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[20]  B. Buyukaydin,et al.  The effect of sleep apnea syndrome on the development of diabetic nephropathy in patients with type 2 diabetes. , 2012, Diabetes research and clinical practice.

[21]  T. Yao,et al.  A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea , 2009, European Respiratory Journal.

[22]  J M Neilson,et al.  Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. , 1991, British heart journal.

[23]  J. Seze.  Obstructive sleep apnoea: an underestimated cause of peripheral neuropathy , 2006 .

[24]  A. Yamashina,et al.  Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction. , 2011, Respiratory medicine.

[25]  A. Malhotra,et al.  Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. , 2009, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[26]  M. Rousseau,et al.  Cardiometabolic phenotype and UKPDS risk in male type 2 diabetic patients with obstructive sleep apnoea , 2009 .

[27]  M. Rousseau,et al.  Sleep apnoea syndrome and 10‐year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance , 2013, Diabetes/metabolism research and reviews.

[28]  P. Ducimetiere,et al.  Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population , 1980, Diabetologia.

[29]  A. Ribeiro,et al.  Relationship among end-stage renal disease, hypertension, and sleep apnea in nondiabetic dialysis patients. , 2005, American journal of hypertension.

[30]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Jianguo Li,et al.  Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. , 2007, American journal of respiratory and critical care medicine.

[32]  J. Hedner,et al.  Impairment of vascular endothelial function and left ventricular filling : association with the severity of apnea-induced hypoxemia during sleep. , 2001, Chest.

[33]  B. Wuyam,et al.  Peripheral neuropathy in sleep apnea. A tissue marker of the severity of nocturnal desaturation. , 1999, American journal of respiratory and critical care medicine.

[34]  G. Pillar,et al.  Sleep, sleep apnea, diabetes, and the metabolic syndrome: the role of treatment. , 2012, Sleep.

[35]  N. Punjabi,et al.  Alterations in Glucose Disposal in Sleep-disordered Breathing. , 2009, American journal of respiratory and critical care medicine.

[36]  C Guilleminault,et al.  Abnormal breathing patterns during sleep in diabetes , 1985, Annals of neurology.

[37]  D. Kripke,et al.  CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. , 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[38]  E. Agardh,et al.  TNF-Alfa is an Independent Serum Marker for Proliferative Retinopathy in Type 1 Diabetic Patients , 2007 .

[39]  P. Giraud,et al.  Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome , 2003, European Respiratory Journal.

[40]  T. Clark,et al.  Sleep Apnoea in Diabetic Patients with Autonomic Neuropathy , 1981, Journal of the Royal Society of Medicine.

[41]  Swastik Agrawal,et al.  CPAP for the metabolic syndrome in patients with obstructive sleep apnea. , 2011, The New England journal of medicine.

[42]  J. Concato,et al.  Obstructive sleep apnea as a risk factor for type 2 diabetes. , 2009, The American journal of medicine.

[43]  A. Tahrani,et al.  Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. , 2012, American journal of respiratory and critical care medicine.

[44]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[45]  J. Stradling,et al.  Prevalence of obstructive sleep apnoea in men with type 2 diabetes , 2006, Thorax.

[46]  Peter Sörös,et al.  Axonal polyneuropathy in obstructive sleep apnoea , 2001, Journal of neurology, neurosurgery, and psychiatry.

[47]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[48]  T. Gislason,et al.  Sleep‐disordered breathing and glucose metabolism in hypertensive men: a population‐based study , 2001, Journal of internal medicine.

[49]  S. Redline,et al.  Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. , 2004, American journal of epidemiology.

[50]  T. Young,et al.  Excess weight and sleep-disordered breathing. , 2005, Journal of applied physiology.

[51]  E. Ringelstein,et al.  Treatment for obstructive sleep apnoea: effect on peripheral nerve function , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[52]  Hakan Buyukoglan,et al.  Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease , 2012, International Urology and Nephrology.

[53]  K. Wroblewski,et al.  Obstructive Sleep Apnea in Young Lean Men , 2012, Diabetes Care.

[54]  J. Ficker,et al.  Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy , 1998, European Respiratory Journal.

[55]  A. Vinik,et al.  Impaired hypoxic ventilatory drive in diabetic patients with autonomic neuropathy. , 1986, The Journal of clinical endocrinology and metabolism.

[56]  Seockhoon Chung,et al.  The effects of nasal continuous positive airway pressure on vascular functions and serum cardiovascular risk factors in obstructive sleep apnea syndrome , 2009, Sleep and Breathing.

[57]  V. Somers,et al.  Impairment of Endothelium-Dependent Vasodilation of Resistance Vessels in Patients With Obstructive Sleep Apnea , 2000, Circulation.

[58]  S. Jacqueminet,et al.  Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[59]  T. Maeno,et al.  Evaluation of the relationship between background factors and sleep-disordered breathing in patients with proliferative diabetic retinopathy , 2011, Japanese Journal of Ophthalmology.

[60]  M. Adachi,et al.  Elevated Levels of C-Reactive Protein and Interleukin-6 in Patients With Obstructive Sleep Apnea Syndrome Are Decreased by Nasal Continuous Positive Airway Pressure , 2003, Circulation.

[61]  C. Guilleminault,et al.  CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. , 2001, Sleep medicine.

[62]  Jun Ren,et al.  Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge , 2012, Clinical and experimental pharmacology & physiology.

[63]  I. Idris,et al.  Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. , 2011, Diabetes technology & therapeutics.

[64]  J. Myśliwska,et al.  The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy. , 2008, Diabetes research and clinical practice.

[65]  J. Rabey,et al.  Hypoxemia correlates with attentional dysfunction in patients with obstructive sleep apnea , 2012, Sleep and Breathing.

[66]  L. Czupryniak,et al.  Treatment with continuous positive airway pressure may affect blood glucose levels in nondiabetic patients with obstructive sleep apnea syndrome. , 2005, Sleep.

[67]  M. Soma,et al.  Complement‐mediated chronic inflammation is associated with diabetic microvascular complication , 2013, Diabetes/metabolism research and reviews.